The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

**Background:** There are sparse data addressing whether standard risk factors for febrile neutropenia (FN) are relevant in patients receiving myelosuppressive chemotherapy and primary prophylaxis for FN, which would have implications for variables to consider during real-world comparative analyses...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang
פורמט: Article
שפה:English
יצא לאור: Columbia Data Analytics, LLC 2021-06-01
סדרה:Journal of Health Economics and Outcomes Research
גישה מקוונת:https://jheor.scholasticahq.com/article/24564-the-impact-of-baseline-risk-factors-on-the-incidence-of-febrile-neutropenia-in-breast-cancer-patients-receiving-chemotherapy-with-pegfilgrastim-prophy.pdf